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e32 Lettersin January 2014, complete remission was sustained.
However, a right side submandibular mass of about
2 3 2 cm was noted incidentally in June 2013.
Computed tomography revealed a cystlike lesion.
The patient and family refused further evaluation of
themass. The size of themass was unchanged during
6 months of follow-up.
IAC has the advantage of delivering a high
concentration of drug to the lesion. Studies by
Harker and Stephen3 showed that a greater con-
centration of 5-FU in the tumor region is achieved
by intra-arterial than by intra-venous administra-
tion. In studies by Claudio et al4 after IAC, 87.5%
of the carcinoma of the facial skin attained
resectability. However, none of the cases was an
adenocarcinoma. IAC has potential for the treat-
ment of refractory neoplasms, and may have
advantages in terms of cosmetic and functional
preservation.
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To the Editor: Urticarial vasculitis is most often
idiopathic, but may occur in association with
autoimmune disease, malignancy, drugs, or infec-
tion. Parasitic infection is a rare cause of urticarial
vasculitis.1 We report a case of urticarial vasculitis
that resolved after the diagnosis and treatment of
neurocysticercosis.
A 36-year-old Ecuadorian agricultural farmer who
immigrated to the United States 20 years ago
presented with new-onset afebrile seizure. Brain
magnetic resonance imaging (MRI) revealed a ring
enhancing cystic lesion (Fig 1). He also complained
of a 3- to 4-month history of intermittent pruritic
‘‘rash’’ over his back, chest, and arms associated with
a ‘‘burning’’ sensation and ‘‘darkening’’ of skin. On
day 2 of hospitalization he reported worsening
pruritus and new lesions on his thighs.
On exam he had partially blanching, edematous
plaques and scattered erythematous papules on both
posterior thighs. Side lighting revealed urticarial
papules on his thighs and trunk. Hypopigmented
macules were present in a linear distribution on
the dorsal upper extremities, with extensive
excoriations. Skin biopsy of a new urticarial papule
demonstrated early leukocytoclastic vasculitis
(Fig 2), leading to a diagnosis of urticarial vasculitis.
Active urticarial lesions persisted for 4 days.
Labs showedawhite bloodcell countof 123109/L,
normal platelets and complement levels and 0%
eosinophils. Serum antibody testing for toxoplas-
mosis, echinococcosis, cysticercosis, trichinellosis,
histoplasmosis, human immunodeficiency virus,
syphilis, and hepatitis was negative. Cerebrospinal
fluid contained 6white blood cells (83% lymphocytes)
andundetectable levelsof cysticercosis IgGantibodies
with enzyme-linked immunosorbent assay (ELISA).
Neurosurgical removal of the cystic lesion demon-
stratedhyalinizedacellularmaterial composedof focal
parasitic remnants, consistent with the scolex of
deceased parasite. The findings of parasite on brain
biopsy, cystic lesions seenonMRI, and seizure fulfilled
absolute, major, and minor criteria, respectively, for
the diagnosis of neurocysticercosis.2 The patient
was started on albendazole (400 mg twice daily)
and his urticarial vasculitis resolved within a few
days. Two years later he remained seizure-free and
rash-free.
Neurocysticercosis is a leading cause of acquired
epilepsy worldwide.2 Following infection, the
cysticerci of Taenia solium remain viable in the
brain and elicit minimal inflammation.3 Only after
several years when a viable cyst degenerates may the
Fig 2. Urticarial vasculitis in a patient with neuro-
cysticercosis seen on skin biopsy specimen from a new
urticarial papule on the left posterior thigh. Extravasated
erythrocytes (yellow arrow) and a perivascular infiltrate
composed of neutrophils with neutrophilic debris
(black arrows), with some mononuclear cells around the
blood vessels, are consistent with an early leukocytoclastic
vasculitis. (Hematoxylin-eosin stain; original magnifica-
tion: 340.)
Fig 1. Neurocysticercosis in a patient with urticarial
vasculitis: brain magnetic resonance imaging shows a
2.5-cm rim enhancing degenerating cyst (arrow) in the
left frontal lobe.
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response.3 The enzyme-linked immunoelectrotrans-
fer blot of serum (not obtained) is the serologic test
of choice, with higher sensitivity and specificity than
ELISA; however, both tests are unreliable in patients
with 1 degenerating cysticercus (as in our patient) or
calcified granulomas.3
Urticarial vasculitis is an uncommon clinicopath-
ologic entity distinct from acute urticaria based on
dermatopathologic findings of vasculitis. Clinically,
urticarial vasculitis presents with painful pruritus and
erythematous wheals lasting longer than 24 hr,followed by a residual hyperpigmentation.4 Our
patient’s differential diagnosis also included
Cysticercus cellulosae cutis ( painless subcutaneous
nodules with larval cysts on biopsy)3 and Sweet
syndrome (associated with pyrexia and neutrophilic
infiltrate on histology without evidence of leuk-
ocytoclastic vasculitis).5 However, biopsy results
combined with urticarial lesions on exam solidified
a diagnosis of urticarial vasculitis.
To our knowledge, urticarial vasculitis associated
with T. solium infection in which the urticarial
vasculitis resolved after neurosurgical removal of
the cyst and treatment with albendazole has not been
reported. Physicians should continue to look for
obscure causes of urticarial vasculitis.
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To the Editor: We present the case of a 29-year-old
woman with glioblastoma multiforme (GBM) who
